Anti-IgE was associated with a lower risk of congestive heart failure, peripheral artery disease, and stroke, whereas anti-IL5/IL5R was associated with a lower risk of congestive heart failure, arrythmia, and peripheral artery disease. Here, IGHE is linked to congestive heart failure.